Zobrazeno 1 - 10
of 304
pro vyhledávání: '"Henry F. Chambers"'
Autor:
Li-Yin Lai, Nidhi Satishkumar, Sasha Cardozo, Vijay Hemmadi, Leonor B. Marques, Liusheng Huang, Sergio R. Filipe, Mariana G. Pinho, Henry F. Chambers, Som S. Chatterjee
Publikováno v:
mBio, Vol 15, Iss 5 (2024)
ABSTRACTInfections caused by Staphylococcus aureus are a leading cause of mortality worldwide. S. aureus infections caused by methicillin-resistant Staphylococcus aureus (MRSA) are particularly difficult to treat due to their resistance to next-gener
Externí odkaz:
https://doaj.org/article/a0422293293f47f1b46805719a1e96df
Autor:
Eva Raphael, Pushkar P. Inamdar, Cheyenne Belmont, Salma Shariff-Marco, Alison J. Huang, Henry F. Chambers
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 12, Iss 1, Pp 1-9 (2023)
Abstract Background Urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (ESBL-E. coli) may occur as outbreaks due to common-source exposures. Yet, it is currently unknown if they cluster geographicall
Externí odkaz:
https://doaj.org/article/67e35c1f65ca46c9914efc6f21c959b6
Autor:
Nadine Rouphael, Patricia Winokur, Michael C. Keefer, Jessica Traenkner, Ana Drobeniuc, Yohei Doi, Sonal Munsiff, Vance G. Fowler, Scott Evans, Randolph E. Oler, Bonifride Tuyishimire, Marina Lee, Varduhi Ghazaryan, Henry F. Chambers
Publikováno v:
mBio, Vol 14, Iss 5 (2023)
ABSTRACT Fosfomycin, approved in the United States only for cystitis, is an attractive alternative for oral treatment of outpatient complicated urinary tract infections (cUTIs) as it has antimicrobial activity against most common uropathogens. The st
Externí odkaz:
https://doaj.org/article/98c2fb484b0e46789b7c1c383fce0a03
Autor:
Pranita D. Tamma, Maria Souli, Michael Billard, Joseph Campbell, Douglas Conrad, Damon W. Ellison, Beth Evans, Scott R. Evans, Kerryl E. Greenwood-Quaintance, Andrey A. Filippov, Holly S. Geres, Toshimitsu Hamasaki, Lauren Komarow, Mikeljon P. Nikolich, Thomas P. Lodise, Seema U. Nayak, Carmelle Norice-Tra, Robin Patel, David Pride, Janie Russell, Daria Van Tyne, Henry F. Chambers, Vance G. FowlerJr, Robert T. Schooley, for the Antibacterial Resistance Leadership Group
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background Bacteriophages (phages) are a promising anti-infective option for human disease. Major gaps remain in understanding their potential utility. Methods This is a randomized, placebo-controlled, double-blind study of a single dose of
Externí odkaz:
https://doaj.org/article/dffc1054d0ed4b0e8d8a816bc72489ab
Autor:
Sook-Ha Fan, Richard A. Proctor, Selvi C. Ersoy, Adhar C. Manna, Ambrose L. Cheung, Friedrich Götz, Henry F. Chambers, Arnold S. Bayer
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT Methicillin-resistant Staphylococcus aureus (MRSA) infections are an increasing concern due to their intrinsic resistance to most standard-of-care β-lactam antibiotics. Recent studies of clinical isolates have documented a novel phenotype,
Externí odkaz:
https://doaj.org/article/c1c2842d93614562ab53cc047089aec1
Autor:
Selvi C. Ersoy, Barbara Gonçalves, Gonçalo Cavaco, Adhar C. Manna, Rita G. Sobral, Cynthia C. Nast, Richard A. Proctor, Henry F. Chambers, Ambrose Cheung, Arnold S. Bayer
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 6 (2022)
ABSTRACT Methicillin-resistant Staphylococcus aureus (MRSA) strains pose major treatment challenges due to their innate resistance to most β-lactams under standard in vitro antimicrobial susceptibility testing conditions. A novel phenotype among MRS
Externí odkaz:
https://doaj.org/article/8917d943fcd94570abddfd92810f8294
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 10, Iss 1, Pp 1-13 (2021)
Abstract Background The prevalence of infections caused by extended-spectrum beta-lactamase producing Escherichia coli (ESBL-E. coli) is increasing worldwide, but the setting in which this increase is occurring is not well defined. We compared trends
Externí odkaz:
https://doaj.org/article/3cd5fc5a0c4146ddb797eb9844b7a8a6
Autor:
Selvi C. Ersoy, Liana C. Chan, Michael R. Yeaman, Henry F. Chambers, Richard A. Proctor, Kevin C. Ludwig, Tanja Schneider, Adhar C. Manna, Ambrose Cheung, Arnold S. Bayer
Publikováno v:
Antibiotics, Vol 11, Iss 4, p 462 (2022)
Methicillin-resistant Staphylococcus aureus (MRSA) regulates resistance to β-lactams via preferential production of an alternative penicillin-binding protein (PBP), PBP2a. PBP2a binds many β-lactam antibiotics with less affinity than PBPs which are
Externí odkaz:
https://doaj.org/article/329a3c32a6454aac89e76ce5f344b0ce
Autor:
Selvi C. Ersoy, Blake M. Hanson, Richard A. Proctor, Cesar A. Arias, Truc T. Tran, Henry F. Chambers, Arnold S. Bayer
Publikováno v:
Genes, Vol 12, Iss 11, p 1650 (2021)
Methicillin-resistant Staphylococcus aureus (MRSA) infections represent a difficult clinical treatment issue. Recently, a novel phenotype was discovered amongst selected MRSA which exhibited enhanced β-lactam susceptibility in vitro in the presence
Externí odkaz:
https://doaj.org/article/3a0d850746cb45ea808e50bf8ec72ec5
Autor:
Selvi C. Ersoy, Warren E. Rose, Robin Patel, Richard A. Proctor, Henry F. Chambers, Ewan M. Harrison, Youngju Pak, Arnold S. Bayer
Publikováno v:
Antibiotics, Vol 10, Iss 9, p 1089 (2021)
Antimicrobial susceptibility testing (AST) is routinely used to establish predictive antibiotic resistance metrics to guide the treatment of bacterial pathogens. Recently, a novel phenotype termed “bicarbonate (NaHCO3)-responsiveness” was identif
Externí odkaz:
https://doaj.org/article/9cbc9a6770de490e872e6b7f70073558